Skip to content
On this page:OverviewPublicationsKey papers
PICO Portalanswers from OpenAlex & ORCID

C. Xu

ResearcherPublications, citations & collaboration network

C. Xu is a researcher indexed in PICO Portal from OpenAlex & ORCID.

How many works does C. Xu have?

PICO Portalindexed works

C. Xu has 391 works in the PICO Portal index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does C. Xu have?

PICO Portalcitation count

C. Xu has 3,174 citations in the OpenAlex counts PICO Portal stores.

What is the h-index of C. Xu?

PICO Portalh-index

C. Xu has an h-index of 31 in OpenAlex.

What is the i10-index of C. Xu?

PICO Portali10-index

C. Xu has an i10-index of 100 in OpenAlex.

What is the ORCID of C. Xu?

PICO Portalorcid

The ORCID for C. Xu is on the source record.

What is the OpenAlex record for C. Xu?

PICO Portalopenalex

The OpenAlex for C. Xu is on the source record.

What are the most-cited papers on C. Xu?

PICO Portalmost cited works
Comparison of droplet digital PCR and conventional quantitative PCR for measuring EGFR gene mutation
Bo Zhang, C. Xu, Yun Shao, H. Wang, YONG-FANG WU, YE-YING SONG, XIAO-BING LI, Zhe Zhang, W.P. Wang, Liqiong Li, CONG-LI CAI
Experimental and Therapeutic Medicine. 2015102 CitationsOPEN ACCESS
Robotic surgical systems in maxillofacial surgery: a review
Hanghang Liu, Longjiang Li, Bin Shi, C. Xu, En Luo
International Journal of Oral Science. 201793 CitationsOPEN ACCESS
TP53 Mutation as Potential Negative Predictor for Response of Anti-CTLA-4 Therapy in Metastatic Melanoma
Wenjing Xiao, Nan Du, Taoyuan Huang, Jinan Guo, Xingkui Mo, Tao Yuan, Yong Chen, Ting Ye, C. Xu, Wenxian Wang, Guoqiang Wang, Shangli Cai, Jing Chen
EBioMedicine. 201884 CitationsOPEN ACCESS
Genomic alterations and clinical outcomes in patients with lung adenocarcinoma with transformation to small cell lung cancer after treatment with EGFR tyrosine kinase inhibitors: A multicenter retrospective study
Wenxian Wang, C. Xu, Huafei Chen, Jinhao Jia, Liping Wang, Huijing Feng, Hong Wang, Zhengbo Song, Nong Yang, Yongchang Zhang
Lung Cancer. 202173 Citations
TP53 mutations predict for poor survival in ALK rearrangement lung adenocarcinoma patients treated with crizotinib
Wenxian Wang, C. Xu, Yanping Chen, Wei Liu, Lihua Zhong, Fangfang Chen, Wu Zhuang, Yunjian Huang, Zhangzhou Huang, Rongrong Chen, Yanfang Guan, Xin Yi, Tang-Feng Lv, Weifeng Zhu, Jianping Lu, Xiaojiang Wang, Yi Shi, Xiandong Lin, Gang Chen, Yong Song
Journal of Thoracic Disease. 201869 CitationsOPEN ACCESS

Related on PICO Portal

470M+ articles · 14-day free trial